reference/35066042

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35066042

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1422-0067
issueIdentifier	16
pageRange	9113-
publicationName	International Journal of Molecular Sciences
startingPage	9113
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_67b284c32bcc871f94f609b25188d832 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b70c84a1b1ee6c18216aeac68fae2b76 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_509288e8ddcb304094455c7bcb4c7937 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_37b0fb92494a51407713af93b1ba812f
bibliographicCitation	Benedetti R, Arena A, Romeo MA, Gilardini Montani MS, Gonnella R, Santarelli R, Trivedi P, Cirone M. Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas. Int J Mol Sci. 2022 Aug 14;23(16). PMID: 36012375; PMCID: PMC9409055.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9574-6304 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1825-9112 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2207-9624 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4894-4986 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8722-7539 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9416-7594 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad7d8ca2391df8b6fc4e088b73947553 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60c5b7a2a5e87375072d10ddc410b048
date	2022-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36012375 https://pubmed.ncbi.nlm.nih.gov/PMC9409055 https://doi.org/10.3390/ijms23169113
isPartOf	https://portal.issn.org/resource/ISSN/1422-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34611
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas
discusses	http://id.nlm.nih.gov/mesh/M0469399 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M000615358 http://id.nlm.nih.gov/mesh/M0007423 http://id.nlm.nih.gov/mesh/M0520610 http://id.nlm.nih.gov/mesh/M000601132
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D056811 http://id.nlm.nih.gov/mesh/D002051Q000188 http://id.nlm.nih.gov/mesh/D000067856Q000494 http://id.nlm.nih.gov/mesh/D002051Q000821 http://id.nlm.nih.gov/mesh/D020031Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004722Q000378 http://id.nlm.nih.gov/mesh/D000071717Q000378 http://id.nlm.nih.gov/mesh/D000071717Q000235 http://id.nlm.nih.gov/mesh/D004722Q000235 http://id.nlm.nih.gov/mesh/D004854Q000502 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017346Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9091f9d0b2e1bc76ac280a84a8e3f42d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_98035231fcaee69b50d4e6e928e41169 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9856 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7124 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_77517a4ebde4224a7c9dbd3c0434d4e4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11073 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9fe2c1798a5a405237495f2a47a80e7b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7494 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2081

Total number of triples: 61.